In particular, CLL cells with XPO1-E571K had enriched expression of several genes known to potentially contribute to lymphocyte activation (i.e. IFNG, GZMB, CCR1, FCN1, and VCAN). This evidence concerns the gene XPO1 and B-cell chronic lymphocytic leukemia.